Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs midazolam for amnesia during painless gastroscopy
ChiCTR2300069708Phase 4Not yet recruiting
- Sponsor
- Yantai Yuhuangding Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and midazolam in None (2 arms), sponsored by Yantai Yuhuangding Hospital. Primary endpoint: anterograde amnesia. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
remimazolammidazolam
Beyond the preview
Go deeper on ChiCTR2300069708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069708.